| Revenue Recognition |
Revenue
by Service Line
| |
Three
Months Ended September 30, |
| |
2018 |
|
2017 |
| Products: |
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
| Functional
neurology |
$ |
1,448,850 |
|
$ |
1,284,029 |
| Biologics
and drug delivery |
|
190,993 |
|
|
136,833 |
| Capital
equipment |
|
99,961 |
|
|
207,573 |
| Total
product revenue |
|
1,739,804 |
|
|
1,628,435 |
| Services: |
|
|
|
|
|
| Capital
equipment and other |
|
62,238 |
|
|
88,635 |
| Biologics
and drug delivery |
|
5,000 |
|
|
- |
| Total
service revenue |
|
67,238 |
|
|
88,635 |
| Total
revenue |
$ |
1,807,042 |
|
$ |
1,717,070 |
| |
Nine
Months Ended September 30, |
| |
2018 |
|
2017 |
| Products: |
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
| Functional
neurology |
$ |
3,787,712 |
|
$ |
4,229,192 |
| Biologics
and drug delivery |
|
483,251 |
|
|
291,023 |
| Capital
equipment |
|
420,039 |
|
|
923,072 |
| Total
product revenue |
|
4,691,002 |
|
|
5,443,287 |
| Services: |
|
|
|
|
|
| Capital
equipment and other |
|
218,742 |
|
|
256,860 |
| Biologics
and drug delivery |
|
167,000 |
|
|
- |
| Total
service revenue |
|
385,742 |
|
|
256,860 |
| Total
revenue |
$ |
5,076,744 |
|
$ |
5,700,147 |
|